Dr Reddy's expands European operations with launch of generics in France

First products, to be available in the hospital market, will belong to oncology & anti-infectives

Dr Reddy's completes acquisition of product portfolio from Teva

Premium

BS B2B Bureau Hyderabad

Last Updated : Feb 14 2017 | 4:13 PM IST

Dr Reddy’s Laboratories Ltd will expand its commercial operations in Europe with the introduction of its portfolio of generics in France. The first products will be made available in the hospital market in March 2017 in the area of oncology and anti-infectives, including antimycotics.

The company recently launched select products of its hospital portfolio in Italy and Spain, and is looking to further strengthen its presence in the two countries with the launch of anti-HIV products this year.

Abhijit Mukherjee, chief operating officer, Dr Reddy’s Laboratories, said, “It is our constant endeavor to enhance the reach of our affordable and difficult-to-produce drugs.

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in